Study Details

Back
Study ID ADV-KT-02-KOR
Study Title A Multicenter, Open-label, Single-arm, Non-inferiority Study to Assess the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, based Immunosuppressive Regimen in Stable Kidney Transplant Patients Converted from a PROGRAF® based Immunosuppressive Regimen
Clinicaltrials.gov Identifier NCT01839929
Compound Name FK506E / tacrolimus extended-release
Medical Indication or Disease Prevention of rejection after organ transplant
Study Sponsor Astellas Pharma Korea, Inc.
Collaborator Not Applicable
Study Start Date 31-Aug-2010
Study Completion Date 31-Jan-2013
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Not Available

QUICK SEARCH

USEFUL LINKS